CG Oncology
catalyst rich calendar through potential first approval and launch followed by bladder indication expansion | CG Oncology
Company
Deck Type
IPO
Sector
Industry
Deck date
March 2024
Slide
33 of 45
Related slides by other companies
Compass Therapeutics
IPO
November 2020
catalyst rich calendar in the next months and beyond | Compass Therapeutics
Theravance Biopharma
Results
August 2023
potential for patients highly differentiated therapy delivering significant market expansion | Theravance Biopharma
MaxCyte
Results
November 2023
partnerships near and long term revenue potential with strong upside in commercial opportunity | MaxCyte
Eutelsat
Results
July 2023
upcoming launches ree over | Eutelsat
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io